Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

IPSS-M - Use for Predicting Survival and Progression in Patients with Ccus - a Retrospective Multi-Institutional Study

Ahmad Nanaa, Aref Al-Kali, Dragan Jevremovic, Phuong L. Nguyen, Patricia Greipp, Rong He, Mrinal M. Patnaik, Abhishek A Mangaonkar, Hassan Alkhateeb, Julia Anderson, Weina Chen, Olga Weinberg, Stephen Chung, Yazan F. Madanat

Blood (2023) 142 (Supplement 1): 4590.

https://doi.org/10.1182/blood-2023-191048

Published: 2023

Journal Articles

Clinical and Genetic Characteristics of STAG2 Mutations in Myeloid Neoplasms

Blood (2022) 140 (Supplement 1): 12353–12354.

https://doi.org/10.1182/blood-2022-155561

Published: 2022

Journal Articles

Large β Globin Gene Cluster Deletions and Implications on Transcription Factor Regulation in Hemoglobin Switching - Α Novel ε G γ Α γ Deletion with Intact LCR

Christineil Thompson, Mira A Kohorst, Aruna Rangan, Jessica M Bortnova, Tavanna R Porter, Phuong L Nguyen, Eric D Wieben, Linda Hasadsri, James D Hoyer, Jennifer L Oliveira

Blood (2021) 138 (Supplement 1): 3083.

https://doi.org/10.1182/blood-2021-151768

Published: 2021

Journal Articles

Clinical Characteristics and Prognosis of Thirty-Three Patients with Myeloid Neoplasms and DDX41 Mutation: Mayo Clinic Experience

Ahmad Nanaa, Aref Al-Kali, David S. Viswanatha, James M. Foran, Talha Badar, Lisa Z. Sproat, Rong He, Phuong L Nguyen, Dragan Jevremovic, Mohamed E Salama, Patricia Greipp, Naseema Gangat, Ayalew Tefferi, Mark R. Litzow, Abhishek A. Mangaonkar, Mithun V. Shah, Mrinal M. Patnaik, Hassan B. Alkhateeb

Blood (2021) 138 (Supplement 1): 3691.

https://doi.org/10.1182/blood-2021-144400

Published: 2021

Journal Articles

Spectrum of Hematological Malignancies in 130 Patients with Germline Predisposition Syndromes - Mayo Clinic Germline Predisposition Study

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-139050

Published: 2020

Journal Articles

Predictors of Survival and Time to Progression to Myeloid Neoplasm in Patients with Clonal Cytopenias

Ahmad Nanaa, Rama Nana, Zhuoer Xie, MD, Dragan Jevremovic, MD PhD, Phuong L. Nguyen, MD, Cynthia Hengel, Susan M. Geyer, PhD, Rong He, MD, David S. Viswanatha, MD, Michael M. Timm, Mohamed E Salama, MD, Min Shi, MDPhD, Patricia Greipp, DO, Hassan B. Alkhateeb, MD, William J Hogan, MB, BCh, Mark Litzow, MD, Mrinal M. Patnaik, MDMBBS, Mithun Vinod Shah, MD PhD, Aref Al-Kali, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-142181

Published: 2020

Journal Articles

Treatment Outcome for Symptomatic Patients with Clonal Cytopenia of Undetermined Significance: A Single-Institution Retrospective Study

Zhuoer Xie, MD, Ahmad Nanaa, Antoine Saliba, MD, Rong He, MD, Phuong L. Nguyen, MD, Dragan Jevremovic, MD PhD, Patricia Greipp, DO, Mohamed Salama, MD, Naseema Gangat, MBBS, Hassan B. Alkhateeb, MD, Ayalew Tefferi, MD, Mark Litzow, MD, Mrinal M. Patnaik, MDMBBS, Mithun Vinod Shah, MD PhD, Aref Al-Kali, MD

Blood (2020) 136 (Supplement 1): 44.

https://doi.org/10.1182/blood-2020-137527

Published: 2020

Journal Articles

History of Autoimmune Disease Is Associated with Increased Risk for Myelodysplastic Syndromes

Michelle A. Roesler, BS, Amy Linabery, PhD MS, Michaela Richardson, MPH, Adina Cioc, MD, Betsy A Hirsch, PhD, Phuong L. Nguyen, MD, Erica D. Warlick, MD, Jenny Poynter, PhD

Blood (2019) 134 (Supplement_1): 3014.

https://doi.org/10.1182/blood-2019-130940

Published: 2019

Journal Articles

Comparison of α LEPRA and α LELY Co-Inheritance with a SPTA1 Whole Gene Deletion, a Family Study

Molly S. Hein, Lea Coon, MS, LCGC, Tavanna R. Porter, MS, LCGC, Rong He, MD, Michelle E. Savedra, MT(ASCP), Laura J. Train, BS, Linnea M. Baudhuin, PhD, Andre M. Oliveira, MD PhD, Phuong L. Nguyen, MD, James D. Hoyer, MD, Aruna Rangan, MD, Jennifer L. Oliveira, MD

Blood (2019) 134 (Supplement_1): 2228.

https://doi.org/10.1182/blood-2019-125691

Published: 2019

Journal Articles

Correlation of Flow Cytometric Aberrations with Cytogenetic, Molecular Genetic, and Morphology in Patients with Unexplained Cytopenias

Haya Azouz, Jessica Ternus, Phuong L. Nguyen, MD, Dragan Jevremovic, MD PhD, Mrinal M Patnaik, MDMBBS, Michael M. Timm, Min Shi, MD PhD, Rong He, MD, David S. Viswanatha, Mithun Vinod Shah, MD PhD, Hassan B. Alkhateeb, MD, Naseema Gangat, MBBS, Kebede H. Begna, MD, William J Hogan, MB, BCh, Mark Litzow, MD, Cindy Hengel, Aref Al-Kali, MD

Blood (2019) 134 (Supplement_1): 5406.

https://doi.org/10.1182/blood-2019-125114

Published: 2019

Journal Articles

Discrepancy of Blast Percentage between the Bone Marrow Aspirate and Flow Cytometry and Its Impact on Survival Outcomes in Patients with Myelodysplastic Syndromes Excess Blast (MDS-EB)

Meera Yogarajah, MD, Phuong L. Nguyen, MD, Rong He, MD, Hassan B. Alkhateeb, MD, Mithun Vinod Shah, MD PhD, Mrinal M Patnaik, MDMBBS, Kebede H. Begna, MD, Michelle A Elliott, MD, Naseema Gangat, MBBS, William J Hogan, MB, BCh, Ayalew Tefferi, MD, Mark Litzow, MD, Aref Al-Kali, MD

Blood (2019) 134 (Supplement_1): 5441.

https://doi.org/10.1182/blood-2019-125439

Published: 2019

Journal Articles

Effects of Voxelotor (GBT440) Therapy on Laboratory Testing of Sickle Cell Patients

Michelle E. Savedra, MT(ASCP), Jessica L. Szuberski, MLS ASCP, Tavanna R. Porter, MS, LCGC, Molly S. Hein, Phuong L. Nguyen, MD, Min Shi, MD PhD, Aruna Rangan, MD, James D. Hoyer, MD, Jennifer L. Oliveira, MD

Blood (2019) 134 (Supplement_1): 1011.

https://doi.org/10.1182/blood-2019-131125

Published: 2019

Journal Articles

Predicted Leukocyte Telomere Length and Risk of Myeloid Neoplasms

Jenny Poynter, PhD, Spencer Kelley, Marina Marcato, Erica Langer, Anthony J Hooten, Mary Rachel Stimson, Michelle A. Roesler, BS, Phuong L. Nguyen, MD, Adina Cioc, MD, Erica D. Warlick, MD, Nathan Pankratz

Blood (2019) 134 (Supplement_1): 1335.

https://doi.org/10.1182/blood-2019-131224

Published: 2019

Journal Articles

Frequency of Acquired Genetic Mutations and Their Prognostic Impact on Patients with Incidental Finding of Isolated 20q- in Bone Marrow without Morphologic Evidence of a Myeloid Neoplasm

Aishwarya Ravindran, MBBS, Rong He, MD, Majd D. Jawad, MD, Rhett P. Ketterling, Dong Chen, MD PhD, Jennifer L. Oliveira, MD, Phuong L. Nguyen, MD, David S. Viswanatha, MD, Kaaren K. Reichard, MD, James D. Hoyer, MD, Ronald S. Go, MD, Min Shi, MD PhD

Blood (2018) 132 (Supplement 1): 4382.

https://doi.org/10.1182/blood-2018-99-117821

Published: 2018

Journal Articles

Factors Predicting Early Mortality in Newly Diagnosed Myelodysplastic Syndrome (MDS): A Population Based Study

Annie M. Jacobsen, MD, Jenny Poynter, PhD, Michaela Richardson, MPH, Phuong L. Nguyen, MD, Betsy A Hirsch, PhD, Adina Cioc, MD, Michelle A. Roesler, BS, Erica D. Warlick, MD

Blood (2018) 132 (Supplement 1): 4369.

https://doi.org/10.1182/blood-2018-99-112319

Published: 2018

Journal Articles

Marrow Blast Percentage Impact on High-Grade Myelodysplastic Syndrome By the Revised International Prognostic Scoring System

Omar Alkharabsheh, MBBS, Mrinal M. Patnaik, MD MBBS, Naseema Gangat, MBBS, Kebede H. Begna, MD, Hassan B. Alkhateeb, MD, Mithun Vinod Shah, MD PhD, William J. Hogan, MBBCh, Rong He, MD, Patricia Greipp, DO, Phuong L. Nguyen, MD, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2018) 132 (Supplement 1): 5510.

https://doi.org/10.1182/blood-2018-99-113943

Published: 2018

Journal Articles

Outcome of Patients Younger Than 50 Years Old Diagnosed with Myelodysplastic Syndromes (MDS): Single Institution Experience

Aref Al-Kali, MD, Rong He, MD, Mrinal M Patnaik, MBBS, David S Viswanatha, MD, Patricia T. Greipp, DO, Darci Zblewski, CNP, Michelle Elliott, MD, Naseema Gangat, MBBS, Ayalew Tefferi, MD, Mark R. Litzow, MD, Phuong L. Nguyen, MD

Blood (2016) 128 (22): 5541.

https://doi.org/10.1182/blood.V128.22.5541.5541

Published: 2016

Journal Articles

Clinical Spectrum of Germline Mutations with Predisposition to Myeloid Neoplasms- 2016 World Health Organization Classification Update

Thanh Ho, MD, Juliana Perez Botero, MD, William J Hogan, MBChB, Saad S Kenderian, MD, Naseema Gangat, MBBS, Ayalew Tefferi, MD, Roshini S Abraham, PhD, Phuong L. Nguyen, MD, Jennifer L Oliveira, MD, Rong He, MD, Dong Chen, MD PhD, David Viswanatha, MD, Vilmarie Rodriguez, MD, Shakila Khan, MD, Mrinal M Patnaik, MBBS

Blood (2016) 128 (22): 300.

https://doi.org/10.1182/blood.V128.22.300.300

Published: 2016

Journal Articles

Association Between Mitochondrial DNA Haplogroup and Myelodysplastic Syndromes

Jenny N Poynter, PhD, Michaela Richardson, Erica Langer, Anthony Hooten, Michelle A. Roesler, BS, Betsy A. Hirsch, PhD, Phuong L. Nguyen, MD, Adina Cioc, MD, Erica Warlick, MD, Julie A Ross, PhD

Blood (2015) 126 (23): 2885.

https://doi.org/10.1182/blood.V126.23.2885.2885

Published: 2015

Journal Articles

Differences In Community and Academic Practice Patterns For Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients In Minnesota: A Population Based Study

Daniel Pease, MD, Julie A Ross, PhD, Phuong L. Nguyen, MD, Betsy Hirsch, PhD, Adina Cioc, MD, Angela R. Smith, MD, MS, Michelle A. Roesler, Rachel K. Fonstad, M.S., Erica D. Warlick, MD

Blood (2013) 122 (21): 2798.

https://doi.org/10.1182/blood.V122.21.2798.2798

Published: 2013

NARROW

IPSS-M - Use for Predicting Survival and Progression in Patients with Ccus - a Retrospective Multi-Institutional Study

Clinical and Genetic Characteristics of STAG2 Mutations in Myeloid Neoplasms

Large β Globin Gene Cluster Deletions and Implications on Transcription Factor Regulation in Hemoglobin Switching - Α Novel ε G γ Α γ Deletion with Intact LCR

Clinical Characteristics and Prognosis of Thirty-Three Patients with Myeloid Neoplasms and DDX41 Mutation: Mayo Clinic Experience

Spectrum of Hematological Malignancies in 130 Patients with Germline Predisposition Syndromes - Mayo Clinic Germline Predisposition Study

Predictors of Survival and Time to Progression to Myeloid Neoplasm in Patients with Clonal Cytopenias

Treatment Outcome for Symptomatic Patients with Clonal Cytopenia of Undetermined Significance: A Single-Institution Retrospective Study

History of Autoimmune Disease Is Associated with Increased Risk for Myelodysplastic Syndromes

Comparison of α LEPRA and α LELY Co-Inheritance with a SPTA1 Whole Gene Deletion, a Family Study

Correlation of Flow Cytometric Aberrations with Cytogenetic, Molecular Genetic, and Morphology in Patients with Unexplained Cytopenias

Discrepancy of Blast Percentage between the Bone Marrow Aspirate and Flow Cytometry and Its Impact on Survival Outcomes in Patients with Myelodysplastic Syndromes Excess Blast (MDS-EB)

Effects of Voxelotor (GBT440) Therapy on Laboratory Testing of Sickle Cell Patients

Predicted Leukocyte Telomere Length and Risk of Myeloid Neoplasms

Frequency of Acquired Genetic Mutations and Their Prognostic Impact on Patients with Incidental Finding of Isolated 20q- in Bone Marrow without Morphologic Evidence of a Myeloid Neoplasm

Factors Predicting Early Mortality in Newly Diagnosed Myelodysplastic Syndrome (MDS): A Population Based Study

Marrow Blast Percentage Impact on High-Grade Myelodysplastic Syndrome By the Revised International Prognostic Scoring System

Outcome of Patients Younger Than 50 Years Old Diagnosed with Myelodysplastic Syndromes (MDS): Single Institution Experience

Clinical Spectrum of Germline Mutations with Predisposition to Myeloid Neoplasms- 2016 World Health Organization Classification Update

Association Between Mitochondrial DNA Haplogroup and Myelodysplastic Syndromes

Differences In Community and Academic Practice Patterns For Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients In Minnesota: A Population Based Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only